DOW JONES27,621.90-338.90 -1.21%
S&P 5003,184.87-41.02 -1.27%
NASDAQ9,122.80-98.48 -1.07%

JMP Securities Initiates Coverage On Karuna Therapeutics with Buy Rating, Announces $122 Price Target

JMP Securities analyst Jason Butler initiates coverage on Karuna Therapeutics (NASDAQ:KRTX) with a Buy rating and a $122 price target.

Benzinga · 01/09/2020 16:21

JMP Securities analyst Jason Butler initiates coverage on Karuna Therapeutics (NASDAQ:KRTX) with a Buy rating and a $122 price target.